| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1006577136 |
| P356 | DOI | 10.1038/AJG.2015.430 |
| P698 | PubMed publication ID | 26832651 |
| P2093 | author name string | Tram T Tran | |
| Joseph Ahn | |||
| Nancy S Reau | |||
| P2860 | cites work | Screening for Hepatitis C Virus Infection in Adults: U.S. Preventive Services Task Force Recommendation Statement | Q22305313 |
| Interventions for nausea and vomiting in early pregnancy | Q24197898 | ||
| Interventionist versus expectant care for severe pre-eclampsia between 24 and 34 weeks' gestation | Q24201038 | ||
| Corticosteroids for HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome in pregnancy | Q24235341 | ||
| Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission | Q24244148 | ||
| Mycophenolate fetal toxicity and risk evaluation and mitigation strategies | Q26822840 | ||
| Hepatitis E, a vaccine-preventable cause of maternal deaths | Q26852254 | ||
| GRADE: an emerging consensus on rating quality of evidence and strength of recommendations | Q27860753 | ||
| Acute fatty liver of pregnancy associated with pancreatitis: a life-threatening complication | Q28246565 | ||
| Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study | Q28294560 | ||
| Acute fatty liver of pregnancy | Q28295222 | ||
| Management and outcome of pregnancy in autoimmune hepatitis | Q28345133 | ||
| The prevalence of hepatitis C virus infection in the United States, 1988 through 1994 | Q29620136 | ||
| Autoimmune hepatitis among fertile women: strategies during pregnancy and breastfeeding? | Q30229501 | ||
| Safety and efficacy of ERCP in pregnancy | Q30434070 | ||
| Gastrointestinal endoscopy in the pregnant woman | Q30437400 | ||
| Ursodeoxycholic acid administration in patients with cholestasis of pregnancy: effects on primary bile acids in babies and mothers | Q32075349 | ||
| Pregnancy complications associated with hepatitis C: data from a 2003-2005 Washington state birth cohort | Q33335491 | ||
| Diagnosis, controversies, and management of the syndrome of hemolysis, elevated liver enzymes, and low platelet count | Q33360652 | ||
| Pregnancy outcomes associated with viral hepatitis | Q33395866 | ||
| How I treat thrombocytopenia in pregnancy | Q33404340 | ||
| Pregnancy in liver cirrhosis. Assessment of maternal and fetal risks in eleven patients and review of the management | Q33491178 | ||
| Prospective study of Hepatitis E Virus infection among pregnant women in France | Q33570861 | ||
| Wilson's disease in pregnancy: case series and review of literature | Q33589081 | ||
| Accuracy of liver function tests for predicting adverse maternal and fetal outcomes in women with preeclampsia: a systematic review | Q33830864 | ||
| A fetal fatty-acid oxidation disorder as a cause of liver disease in pregnant women | Q33863717 | ||
| ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. | Q33990220 | ||
| Successful empiric treatment of HSV hepatitis in pregnancy. Case report and review of the literature | Q41001129 | ||
| Laparoscopic cholecystectomy during pregnancy. Review of anesthetic management, surgical considerations | Q41003191 | ||
| Vertical transmission of hepatitis A resulting in an outbreak in a neonatal intensive care unit | Q41087663 | ||
| Clinical value of maternal bile Acid quantification in intrahepatic cholestasis of pregnancy as an adverse perinatal outcome predictor | Q41345806 | ||
| Treatment of Wilson's disease with zinc. XVII: treatment during pregnancy | Q41925058 | ||
| Efficacy and safety of tenofovir disoproxil fumarate in pregnancy to prevent perinatal transmission of hepatitis B virus. | Q42216418 | ||
| Cesarean section reduces perinatal transmission of hepatitis B virus infection from hepatitis B surface antigen-positive women to their infants | Q42264402 | ||
| -Therapy with ursodeoxycholic acid in primary biliary cirrhosis in pregnancy-. | Q42556106 | ||
| Transjugular liver biopsy: What to do and what not to do. | Q42560565 | ||
| A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection | Q42606604 | ||
| Prenatal exposure to mycophenolate mofetil: an updated estimate. | Q42836538 | ||
| Safe use of ursodeoxycholic acid in a breast-feeding patient with primary biliary cirrhosis. | Q42974482 | ||
| Viral load in HCV RNA-positive pregnant women | Q43034479 | ||
| Herpes simplex virus hepatitis - it's high time we consider empiric treatment. | Q43767812 | ||
| Abnormal liver function tests as predictors of adverse maternal outcomes in women with preeclampsia | Q44047707 | ||
| Diagnosis and treatment of autoimmune hepatitis | Q44080061 | ||
| Good maternal and fetal outcomes for pregnant women with primary biliary cirrhosis. | Q44144082 | ||
| Safety of thiopurines and anti-TNF-α drugs during pregnancy in patients with inflammatory bowel disease. | Q44144568 | ||
| Liver enzyme elevation induced by hyperemesis gravidarum: aetiology, diagnosis and treatment | Q44305675 | ||
| Risk factors, management, and outcomes of hemolysis, elevated liver enzymes, and low platelets syndrome and elevated liver enzymes, low platelets syndrome | Q44577112 | ||
| Transient fetal myelosuppressive effect of D-penicillamine when used in pregnancy. | Q44694189 | ||
| Maternal features of obstetric cholestasis: 20 years experience at King George V Hospital | Q44789945 | ||
| Pregnancy outcomes following systemic prenatal acyclovir exposure: Conclusions from the international acyclovir pregnancy registry, 1984-1999. | Q44860225 | ||
| Ursodeoxycholic acid for intrahepatic cholestasis of pregnancy: good for the mother, not bad for the baby | Q45146404 | ||
| Vertical Transmission of Hepatitis B Antigen in Taiwan | Q45146867 | ||
| Perinatal transmission of hepatitis B virus: an Australian experience | Q45384871 | ||
| Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection | Q45402345 | ||
| Low detection rate and maternal provenance of hepatitis B virus S gene mutants in cases of failed postnatal immunoprophylaxis in England and Wales | Q45759628 | ||
| Outcome of perinatal hepatitis B virus exposure is dependent on maternal virus load | Q45781809 | ||
| Health history after intrahepatic cholestasis of pregnancy. | Q45814309 | ||
| Role of caesarean section in prevention of mother-infant transmission of hepatitis B virus | Q45839723 | ||
| The prevalence of intrahepatic cholestasis of pregnancy in a primarily Latina Los Angeles population. | Q46025554 | ||
| Intrahepatic cholestasis of pregnancy and associated hepatobiliary disease: a population-based cohort study | Q46111528 | ||
| The outcomes of pregnancy in patients with cirrhosis: a population-based study | Q46136397 | ||
| Hypothyroidism and dyshormonogenesis induced by D-penicillamine in children with Wilson's disease and healthy infants born to a mother with Wilson's disease | Q46241850 | ||
| Endoscopic retrograde cholangiopancreatography in pregnancy | Q46245056 | ||
| Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks' gestation (HYPITAT): a multicentre, open-label randomised controlled trial. | Q46333378 | ||
| A prospective national study of acute fatty liver of pregnancy in the UK. | Q46336995 | ||
| Cirrhosis and portal hypertension in pregnancy | Q46357995 | ||
| Pregnancy in chronic active hepatitis | Q46386443 | ||
| Pregnancy in patients with hepatic cirrhosis. Management and outcome | Q46396550 | ||
| Should aciclovir be given to all patients presenting with acute liver failure of unknown etiology? | Q46597616 | ||
| Propofol versus traditional sedative agents for gastrointestinal endoscopy: a meta-analysis | Q46791641 | ||
| Preeclampsia and liver infarction in early pregnancy associated with the antiphospholipid syndrome | Q46889743 | ||
| Pregnancy under sirolimus-based immunosuppression | Q46958693 | ||
| Successful pregnancies and abortions in symptomatic and asymptomatic Wilson's disease | Q47319955 | ||
| Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: variable expressivity of maternal illness during pregnancy and unusual presentation with infantile cholestasis and hypocalcaemia | Q47628935 | ||
| Pregnancy in autoimmune hepatitis: outcome and risk factors | Q47858204 | ||
| Intrahepatic cholestasis of pregnancy as an indicator of liver and biliary diseases: a population-based study | Q50165058 | ||
| Outcomes following cholecystectomy in pregnant and nonpregnant women | Q50177477 | ||
| Intrahepatic cholestasis of pregnancy: a French prospective study. | Q51574209 | ||
| Elective forceps delivery and extradural anaesthesia in a primigravida with portal hypertension and oesophageal varices. | Q51578675 | ||
| Acute fatty liver of pregnancy, hemolysis, elevated liver enzymes, and low platelets syndrome, and long chain 3-hydroxyacyl-coenzyme A dehydrogenase deficiency. | Q51578778 | ||
| Which drugs are contraindicated during breastfeeding? Practice guidelines | Q34050758 | ||
| Diagnosis and management of autoimmune hepatitis | Q34118165 | ||
| Review of the course and outcome of 100 pregnancies in 84 women treated with tacrolimus | Q34127522 | ||
| Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study | Q34152305 | ||
| Standardized Mississippi Protocol treatment of 190 patients with HELLP syndrome: slowing disease progression and preventing new major maternal morbidity | Q34158214 | ||
| Pregnancy after liver transplantation with tacrolimus immunosuppression: a single center's experience update at 13 years | Q34287276 | ||
| Pregnancy in primary biliary cirrhosis complicated by portal hypertension: report of a case and review of the literature | Q34316236 | ||
| Maternal morbidity and mortality in 442 pregnancies with hemolysis, elevated liver enzymes, and low platelets (HELLP syndrome) | Q34344424 | ||
| Quantification of viral DNA and liver enzymes in plasma improves early diagnosis and management of herpes simplex virus hepatitis | Q34354018 | ||
| Recovery of menstruation and pregnancy after liver transplantation | Q34391563 | ||
| Hyperemesis gravidarum, a literature review | Q34432644 | ||
| Understanding and managing HELLP syndrome: the integral role of aggressive glucocorticoids for mother and child | Q34516456 | ||
| Trends in herpes simplex virus type 1 and type 2 seroprevalence in the United States | Q34559709 | ||
| Reducing risk for mother-to-infant transmission of hepatitis C virus: a systematic review for the U.S. Preventive Services Task Force | Q34600737 | ||
| Prevalence of Intrahepatic Cholestasis of Pregnancy in Chile | Q34708913 | ||
| Concentrations of tenofovir and emtricitabine in breast milk of HIV-1-infected women in Abidjan, Cote d'Ivoire, in the ANRS 12109 TEmAA Study, Step 2 | Q34737231 | ||
| Effect of elective cesarean section on the risk of mother-to-child transmission of hepatitis B virus | Q34739466 | ||
| Diagnosis and treatment of Wilson disease: an update | Q34782089 | ||
| Hyperemesis gravidarum | Q34818086 | ||
| Corticosteroid use during pregnancy and risk of orofacial clefts | Q34828505 | ||
| Early pregnancy azathioprine use and pregnancy outcomes | Q34974014 | ||
| Pregnancy outcome in liver transplant recipients | Q35173101 | ||
| Prospective study of liver dysfunction in pregnancy in Southwest Wales | Q35595174 | ||
| Acyclovir prophylaxis to prevent herpes simplex virus recurrence at delivery: a systematic review | Q35602838 | ||
| The prevalence of hepatitis B and C viral infections among pregnant women | Q35915820 | ||
| Reproduction and transplantation: report on the AST Consensus Conference on Reproductive Issues and Transplantation | Q36155827 | ||
| Good pregnancy outcome despite intrahepatic cholestasis. | Q36234131 | ||
| Pregnancy after liver transplantation: report of 8 new cases and review of the literature. | Q36458839 | ||
| Pregnancy outcome after liver transplantation: a single-center experience of 71 pregnancies in 45 recipients | Q36519141 | ||
| Gastrointestinal endoscopy in pregnant and lactating women: emerging standard of care to guide decision-making | Q36654510 | ||
| Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants | Q36733578 | ||
| The CARI guidelines. Calcineurin inhibitors in renal transplantation: pregnancy, lactation and calcineurin inhibitors | Q36742555 | ||
| Detection and diagnosis of herpes simplex virus infection in adults with acute liver failure | Q36746428 | ||
| A review of the management of gallstone disease and its complications in pregnancy | Q37211377 | ||
| Tacrolimus placental transfer at delivery and neonatal exposure through breast milk. | Q37353469 | ||
| Safety and utility of ERCP during pregnancy | Q37366127 | ||
| Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994 | Q37389167 | ||
| Systematic review: clinical efficacy of chelator agents and zinc in the initial treatment of Wilson disease | Q37390775 | ||
| Management strategies for hyperemesis. | Q37406499 | ||
| Safety of ultrasonography in pregnancy: WHO systematic review of the literature and meta-analysis | Q37416569 | ||
| Tetrada of the possible mycophenolate mofetil embryopathy: a review | Q37505586 | ||
| Treatment options for autoimmune hepatitis: a systematic review of randomized controlled trials | Q37733093 | ||
| Mitochondrial fatty acid oxidation disorders: clinical presentation of long-chain fatty acid oxidation defects before and after newborn screening | Q37744748 | ||
| Consequences of hyperemesis gravidarum for offspring: a systematic review and meta-analysis | Q37900364 | ||
| Risks versus benefits of gastrointestinal endoscopy during pregnancy | Q37942293 | ||
| An algorithm for risk assessment and intervention of mother to child transmission of hepatitis B virus | Q37955548 | ||
| Outcomes of pregnancy in women with autoimmune hepatitis. | Q37977274 | ||
| Pregnancy outcomes of liver transplant recipients: a systematic review and meta-analysis | Q37985682 | ||
| Hepatic rupture in hemolysis, elevated liver enzymes, low platelets syndrome | Q37987011 | ||
| Systematic review and meta-analysis on the effects of thiopurines on birth outcomes from female and male patients with inflammatory bowel disease | Q37995572 | ||
| Systematic review of haemorrhage and rupture of hepatocellular adenomas | Q38012403 | ||
| Pre-eclampsia/eclampsia and hepatic rupture | Q38020297 | ||
| Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis | Q38034598 | ||
| Pregnancy and extrahepatic portal hypertension. Review and report on the management | Q38034981 | ||
| The fetal safety of thiopurines for the treatment of inflammatory bowel disease in pregnancy. | Q38069239 | ||
| Ciclosporin use during pregnancy | Q38091657 | ||
| How safe are anti-rheumatic drugs during pregnancy? | Q38092400 | ||
| Quantifying the global rates of nausea and vomiting of pregnancy: a meta analysis | Q38122281 | ||
| Breastfeeding and tacrolimus: is it a reasonable approach? | Q38125241 | ||
| Fulminant hepatic failure caused by acute fatty liver of pregnancy treated by orthotopic liver transplantation | Q38138045 | ||
| Successful maternal and fetal outcome in a kidney transplant patient with everolimus exposure throughout pregnancy: a case report | Q38186160 | ||
| The use of magnetic resonance imaging in the obstetric patient | Q38209569 | ||
| Pregnancy in women with primary biliary cirrhosis | Q38216198 | ||
| Prognosis and determinants of pregnancy outcome among patients with post-hepatitis liver cirrhosis | Q39384771 | ||
| Follow-up of pregnant women with autoimmune hepatitis: the disease behavior along with maternal and fetal outcomes. | Q39518046 | ||
| Report from the National Transplantation Pregnancy Registry (NTPR): outcomes of pregnancy after transplantation. | Q40224887 | ||
| Pregnancy and esophageal varices | Q40279758 | ||
| Herpes simplex virus hepatitis: an analysis of the published literature and institutional cases | Q40438022 | ||
| Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. | Q40481264 | ||
| Pregnancy in a patient with Wilson's disease treated with D-penicillamine and zinc sulfate. A case report and review of the literature | Q40590133 | ||
| Hepatic infarction associated with eclampsia | Q40762477 | ||
| Infant with severe penicillamine embryopathy born to a woman with Wilson disease. | Q52088981 | ||
| Pregnancy outcome after cyclosporine therapy during pregnancy: a meta-analysis. | Q52931732 | ||
| Pregnancies following liver transplantation--how safe are they? A report of 19 cases under cyclosporine A and tacrolimus. | Q52992599 | ||
| Life-threatening hemorrhage from adenomas in the liver during pregnancy. | Q53531308 | ||
| Acyclovir in pregnancy registry: six years' experience. The Acyclovir in Pregnancy Registry Advisory Committee | Q53710364 | ||
| Pregnancy in a kidney transplant patient treated with everolimus. | Q53807157 | ||
| Primary biliary cirrhosis | Q56428273 | ||
| Transjugular intrahepatic portosystemic shunt: a case report of rescue management of unrestrainable variceal bleeding in a pregnant woman | Q56993049 | ||
| Successful pregnancy in a woman with liver cirrhosis complicated by recurrent variceal bleeding | Q60221698 | ||
| Prenatal exposure to penicillamine and oral clefts: Case report | Q60326029 | ||
| Effect of pregnancy on chronic hepatitis C: a case-control study | Q62658366 | ||
| Lethal effects of normeperidine | Q68125295 | ||
| Apparent liver blood flow during pregnancy: a serial study using indocyanine green clearance | Q68920426 | ||
| Intrapartum orthotopic liver transplantation with successful outcome of pregnancy | Q68924096 | ||
| Pregnancy in chronic active hepatitis with cirrhosis | Q69427153 | ||
| Risk status and pregnancy outcome among medicaid recipients | Q69516008 | ||
| The influence of age on the development of the hepatitis B carrier state | Q70476628 | ||
| Successful in vitro fertilization and pregnancy in a patient with autoimmune chronic active hepatitis and cirrhosis | Q72327808 | ||
| Performance of ERCP for symptomatic choledocholithiasis during pregnancy: techniques to increase safety and improve patient management | Q72688358 | ||
| Safety of ERCP during pregnancy | Q73012293 | ||
| Pregnancy and liver disease | Q73122648 | ||
| Prophylactic banding of severe esophageal varices associated with liver cirrhosis in pregnancy | Q73145373 | ||
| Neonatal cholestasis resulting from vertical transmission of hepatitis A infection | Q73313011 | ||
| Wilson's disease and pregnancy | Q73401751 | ||
| Cyclosporine excretion into breast milk | Q73582420 | ||
| Breast-feeding by a cyclosporine-treated mother | Q73835435 | ||
| Endoscopic band ligation: a safe technique to control bleeding esophageal varices in pregnancy | Q77151002 | ||
| Pregnancy after liver transplantation with tacrolimus | Q80110032 | ||
| Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group | Q80203918 | ||
| ACOG Practice Bulletin. Clinical management guidelines for obstetrician-gynecologists. No. 82 June 2007. Management of herpes in pregnancy | Q80478565 | ||
| ACOG Committee Opinion. Number 299, September 2004 (replaces No. 158, September 1995). Guidelines for diagnostic imaging during pregnancy | Q80512377 | ||
| Liver disease in pregnancy | Q80674317 | ||
| Transjugular liver biopsy: a retrospective analysis of 601 cases | Q80760923 | ||
| Pre-eclampsia | Q81446389 | ||
| Prophylactic endoscopic band ligation of esophageal varices during pregnancy | Q81490967 | ||
| Liver transplantation for HELLP syndrome | Q81552769 | ||
| Cyclosporine and lactation: when the mother is willing to breastfeed | Q83217982 | ||
| Telbivudine prevents vertical transmission from HBeAg-positive women with chronic hepatitis B | Q83462911 | ||
| Hypertension in pregnancy | Q84088968 | ||
| An additional patient with mycophenolate mofetil embryopathy: cardiac and facial analyses | Q84146488 | ||
| Positive outcome in a patient with Wilson's disease treated with reduced zinc dosage in pregnancy | Q84561170 | ||
| Outcome of pregnancy in patients with autoimmune hepatitis/primary biliary cirrhosis overlap syndrome: a report of two cases | Q84588815 | ||
| Pregnancy under everolimus-based immunosuppression | Q84994803 | ||
| Follow-up of tacrolimus breastfed babies | Q85007194 | ||
| How accurate are the Swansea criteria to diagnose acute fatty liver of pregnancy in predicting hepatic microvesicular steatosis? | Q85180488 | ||
| No evidence of substantial growth progression or complications of large focal nodular hyperplasia during pregnancy | Q85315302 | ||
| P2507 | corrigendum / erratum | Corrigendum: ACG Clinical Guideline: Liver Disease and Pregnancy. | Q53941642 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 176-94; quiz 196 | |
| P577 | publication date | 2016-02-02 | |
| P1433 | published in | The American Journal of Gastroenterology | Q7713501 |
| P1476 | title | ACG Clinical Guideline: Liver Disease and Pregnancy | |
| P478 | volume | 111 |
| Q30235293 | Acute Fatty Liver Disease of Pregnancy: Updates in Pathogenesis, Diagnosis, and Management |
| Q55049883 | Acute Kidney Injury in Pregnancy: The Changing Landscape for the 21st Century. |
| Q98735898 | Acute-on-Chronic Liver Failure in Pregnant Patients with Chronic Hepatitis B: A Retrospective Observational Case Series Study |
| Q60928361 | Assessment of Pharmaceutical Company and Device Manufacturer Payments to Gastroenterologists and Their Participation in Clinical Practice Guideline Panels |
| Q64072256 | Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses |
| Q92166689 | Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the study of liver diseases |
| Q94474351 | Dysregulation of bile acids increases the risk for preterm birth in pregnant women |
| Q55505691 | Gastrointestinal diseases during pregnancy: what does the gastroenterologist need to know? |
| Q87898170 | Hepatic diagnostics in pregnancy: Biopsy, biomarkers, and beyond |
| Q54966059 | Hepatic infarction induced by HELLP syndrome: a case report and review of the literature. |
| Q98210332 | Hepatitis B infection and intrahepatic cholestasis of pregnancy: A systematic review and meta-analysis |
| Q54226744 | Hepatitis C in Pregnancy. |
| Q92276031 | Indian National Association for the Study of the Liver-Federation of Obstetric and Gynaecological Societies of India Position Statement on Management of Liver Diseases in Pregnancy |
| Q47982941 | Jaundice and Pregnancy: Why Going Viral Is Out of Style |
| Q47292488 | Laparoscopic liver resection for hemorrhagic hepatocellular adenoma in a pregnant patient |
| Q87781341 | Liver Disease in Pregnancy: Beyond the Guidelines |
| Q89560897 | Liver Disease in Pregnancy: What's New |
| Q47572997 | Liver Dysfunction during Pregnancy and Its Association of With Preterm Birth in China: A Prospective Cohort Study |
| Q92149102 | Population Scale Retrospective Analysis Reveals Potential Risk of Cholestasis in Pregnant Women Taking Omeprazole, Lansoprazole, and Amoxicillin |
| Q64075585 | Preeclampsia Induced Liver Dysfunction Complicated by Disseminated Intravascular Coagulopathy and Placental Abruption: A Case Report and Review of the Literature |
| Q38707441 | Pregnancy Outcome in Women Undergoing Liver Biopsy During Pregnancy: A Nationwide Population-Based Cohort Study |
| Q53700655 | Pregnancy in a patient with portal hypertension secondary to liver cirrhosis. |
| Q89344544 | Response to Braillon et al |
| Q88658560 | Response to Morton |
| Q53941642 | Corrigendum: ACG Clinical Guideline: Liver Disease and Pregnancy. | main subject | P921 |
Search more.